Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients
Anna Pawłowska, Wiktoria Skiba, Dorota Suszczyk, et al.
Cancers (2022) Vol. 14, Iss. 23, pp. 5757-5757
Open Access | Times Cited: 15

Showing 15 citing articles:

Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 245
Targeting oral tumor microenvironment for effective therapy
Hendrik Setia Budi, Bagher Farhood
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Current Understanding on Why Ovarian Cancer Is Resistant to Immune Checkpoint Inhibitors
Anna Pawłowska, Anna K. Rekowska, Weronika Kuryło, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10859-10859
Open Access | Times Cited: 25
Immunotherapies in rare cancers
Sneha Vivekanandhan, Deborah Bahr, Ashish Kothari, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 22
The Role of Different Immunocompetent Cell Populations in the Pathogenesis of Head and Neck Cancer—Regulatory Mechanisms of Pro- and Anti-Cancer Activity and Their Impact on Immunotherapy
Katarzyna Starska
Cancers (2023) Vol. 15, Iss. 6, pp. 1642-1642
Open Access | Times Cited: 22
Ovarian cancer treatment and natural killer cell-based immunotherapy
Zhongru Fan, Dongyu Han, Xin Fan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Predictive value of NUF2 for prognosis and immunotherapy responses in pan-cancer.
Yaobin Wang, Liuyan Chen, Yiling Luo, et al.
PubMed (2025) Vol. 45, Iss. 1, pp. 137-149
Closed Access
Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access
Immuno-PET Imaging of a 68Ga-Labeled Single-Domain Antibody for Detecting Tumor TIGIT Expression
Dinghu Weng, Rong Guo, Yu Gao, et al.
Molecular Pharmaceutics (2025)
Closed Access
TIGIT: A potential immunotherapy target for gynecological cancers
Siyue Jiang, Wen-Hua Wang, Yongxiu Yang
Pathology - Research and Practice (2024) Vol. 255, pp. 155202-155202
Closed Access | Times Cited: 1
Immune checkpoint expression and co-expression landscape in gastroesophageal adenocarcinoma
Yeshwanth Vedire, Sukumar Kalvapudi, R. J. Seager, et al.
ESMO Gastrointestinal Oncology (2024) Vol. 3, pp. 100045-100045
Open Access | Times Cited: 1
The World of Immunotherapy Needs More Than PD-1/PD-L1—Two of the New Kids on the Block: LAG-3 and TIGIT
João Martins Gama, Paulo Ricardo Teixeira, Rui Caetano Oliveira
Onco (2024) Vol. 4, Iss. 3, pp. 116-130
Open Access | Times Cited: 1
Uncovering the Expression Pattern of the Costimulatory Receptors ICOS, 4-1BB, and OX-40 in Exhausted Peripheral and Tumor-Infiltrating Natural Killer Cells from Patients with Cervical Cancer
José Manuel Rojas‐Díaz, Fabiola Solorzano‐Ibarra, Nadia Tatiana Garcia-Barrientos, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8775-8775
Open Access | Times Cited: 1
Prognostic and Immunological Implications of FAM72A in Pan-Cancer and Functional Validations
Yuwen Bai, Kui Cao, Ping Zhang, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 375-375
Open Access | Times Cited: 4
Pan-cancer analysis of IRF1 focusing on prognostic and immunological roles in non-small cell lung cancer
Weiling Sun, Kui Cao, Siran Wang, et al.
Heliyon (2024) Vol. 10, Iss. 22, pp. e39861-e39861
Open Access
Epithelial Ovarian Cancer: Microenvironment and Immunecheck Point Inhibitors
Zineb Kabala, Mouna Bourhafour, T. Chekrine, et al.
European Journal of Medical and Health Sciences (2023) Vol. 5, Iss. 5, pp. 17-26
Open Access
Page 1

Scroll to top